JOHN BAILLIE
Pilots at Colorado Ave, Durham, NC
License number
North Carolina A2272201
Issued Date
Jul 2016
Expiration Date
Jul 2018
Category
Airmen
Type
Authorized Aircraft Instructor
Address
Address
3943 Colorado Ave, Durham, NC 27707
Professional information
Ethyl Nitrite As A Gastrointestinal Smooth Muscle Relaxant And Diagnostic And Therapeutic Uses Thereof
US Patent:
7968533, Jun 28, 2011
Filed:
Mar 7, 2007
Appl. No.:
11/715594
Inventors:
Kevin P. Hurley - Chapel Hill NC, US
Jonathan S. Stamler - Chapel Hill NC, US
John Baillie - Durham NC, US
James D. Reynolds - Durham NC, US
Stephen O. Vaughan - Chapel Hill NC, US
Jonathan S. Stamler - Chapel Hill NC, US
John Baillie - Durham NC, US
James D. Reynolds - Durham NC, US
Stephen O. Vaughan - Chapel Hill NC, US
Assignee:
Duke University - Durham NC
International Classification:
A01N 43/00, A61K 31/33
US Classification:
514183, 514645
Abstract:
The present invention provides compositions comprising a gas and a gastrointestinal smooth muscle relaxing agent comprising ethyl nitrite in a therapeutically effective amount. The present invention also provides methods of relaxing gastrointestinal smooth muscle, alleviating contraction or spasm of gastrointestinal smooth muscle to facilitate a diagnostic medical procedure and treating or preventing a gastrointestinal disorder using the compositions of the invention.
Methods For Preventing Post Endoscopic Retrograde Cholangiopancreatography Pancreatitis
US Patent:
2006000, Jan 5, 2006
Filed:
May 16, 2005
Appl. No.:
11/130428
Inventors:
Seymour Fein - New Canaan CT, US
Edward Purich - Silver Spring MD, US
Paul Jowell - Chapel Hill NC, US
John Baillie - Durham NC, US
Edward Purich - Silver Spring MD, US
Paul Jowell - Chapel Hill NC, US
John Baillie - Durham NC, US
International Classification:
A61K 38/54
US Classification:
424094200
Abstract:
The invention relates generally to methods for preventing post endoscopic retrograde cholangiopancreatography pancreatitis (ERCP). The method comprises administering a therapeutically effective amount of a pharmaceutical composition comprising secretin and a pharmaceutically acceptable carrier.